Trisomy 20p syndrome

Trisomy 20p syndrome (also known as duplication 20p or partial trisomy 20p) is a rare chromosomal disorder caused by the presence of an extra copy of the short arm (p) of chromosome 20, resulting in three copies of genetic material from this region instead of the usual two. This condition is classified under partial autosomal trisomies (ICD-10: Q92.2) and can arise de novo or be inherited from a parent carrying a balanced chromosomal rearrangement such as a translocation or inversion. The syndrome primarily affects the neurological, musculoskeletal, and craniofacial systems. Key clinical features include intellectual disability of variable severity, developmental delay (particularly speech and motor milestones), distinctive facial features such as a round face, prominent forehead, short nose with a broad nasal bridge, thin upper lip, and dental anomalies. Affected individuals may also present with hypotonia (low muscle tone), short stature, skeletal abnormalities, and congenital heart defects in some cases. Seizures have been reported in a subset of patients. The phenotype can vary considerably depending on the size of the duplicated segment and whether additional chromosomal imbalances are present. There is currently no cure for trisomy 20p syndrome, and management is supportive and symptom-based. Treatment typically involves early intervention programs including speech therapy, physical therapy, occupational therapy, and special education services. Cardiac anomalies, seizures, and other medical complications are managed according to standard clinical protocols. Regular developmental assessments and multidisciplinary follow-up are recommended to optimize outcomes and quality of life for affected individuals.

Common questions about Trisomy 20p syndrome